Skip to content

Moxibustion for chronic atrophic gastritis: A multicenter randomized controlled clinical trial

Moxibustion for chronic atrophic gastritis: A multicenter randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074688
Enrollment
Unknown
Registered
2023-08-14
Start date
2023-08-14
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic atrophic gastritis

Interventions

Sham moxibustion group:Sham moxibustion

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for chronic atrophic gastritis; (2) Meet the diagnosis of spleen and stomach deficiency syndrome; (3) Aged between 18-75 years, gender unrestricted; (4) Voluntarily participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Autoimmune gastritis (type A chronic atrophic gastritis); (2) Patients with positive C-13 urea breath test at enrollment (Hp infection); (3) Patients diagnosed with or unable to exclude malignant tumors, especially esophageal cancer and gastric cancer; patients with other upper gastrointestinal lesions such as peptic ulcers or Barrett's esophagus; (4) Patients with severe lesions in major organs (heart, liver, kidney, lungs, etc.); (5) Pregnant and lactating women; (6) Patients with infectious diseases such as tuberculosis, hepatitis, AIDS, etc.; (7) Patients with obvious bleeding tendencies or skin diseases unsuitable for moxibustion or severe diabetes; (8) Patients who have received moxibustion treatment or are participating in other clinical research projects.

Design outcomes

Primary

MeasureTime frame
The operative link for gastritis assessment;

Secondary

MeasureTime frame
TCM symptom scoring;PG?, PG?, PGR, Gastrin-17;The operative link on gastric intestinal metaplasia assessment;Self-Rating Anxiety Scale;Self-rating depression scale;12-item short-form health survey;Safety assessment;

Countries

China

Contacts

Public ContactHuangan Wu

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

wuhuangan@126.com+86 136 0161 1239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026